Navigation Links
Angioplasty plus stenting better than thrombolysis for elderly patients with AMI,,

Comparative trials and observational studies previously conducted in elderly populations have yielded conflicting results, researchers explain. These studies were performed before intracoronary stents and use of glycoprotein IIb/IIIa antagonists were routinely employed.
Therefore, Dr. Hanoch Hod, of Chaim Sheba Medical //Center in Tel Hashomer, Israel, and associates followed 130 consecutive patients aged 70 or older treated for ST-elevation AMI. Eighty-six patients were admitted to one center where they were treated with thrombolytic therapy. The 44 admitted to a second center underwent primary angioplasty, except for one referred for bypass graft surgery.

Baseline characteristics of the two groups of patients, as well as transport times to treatment centers, were similar. None of the patients had contraindications for thrombolytic therapy. During their hospitalizations, patients receiving thrombolytic therapy were more likely to experience recurrent ischemia (31%) than primary angioplasty patients (2%) and to require revascularization procedures (48% versus 5%). None of those who underwent primary angioplasty experienced major bleeding, compared with 17% of those in the thrombolysis group. As a consequence, there was a trend toward shorter hospitalizations among those immediately treated with angioplasty (mean 12 days versus 9.1 days).

Finally, the rate of recurrent MI during 6-month follow-up was 14% in the thrombolysis group and 2% in the percutaneous intervention group, the Israeli physicians report.
Dr. Hod's team concludes that, for treatment of elderly patients with acute myocardial infarction ,primary angioplasty with the routine use of coronary stents and intensive antiplatelet therapy is associated with better outcomes than treatment with tissue-type plasminogen activator (t-PA). However, they emphasize that their findings "apply only to a center that specializes in this reperfusion technique and is equipped and staff
'"/>




Page: 1 2

Related medicine news :

1. Cholesterol Drug Helps After Angioplasty
2. Angioplasty Should be the Standard
3. The Success Rate Of Angioplasty In Female Patients Low
4. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
5. Angioplasty death risk reduced by doubling drug dose
6. Angioplasty death risk reduced by doubling drug dose
7. A ray of hope in Angioplasty dilemma
8. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
9. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
10. Drug-Coated Stents Work Better In Diabetic Patients After Angioplasty
11. Togadiyas Condition Stable After Undergoing Angioplasty
Post Your Comments:
(Date:7/1/2015)... New York, NY (PRWEB) , ... July 01, 2015 , ... ... around which DNA is wound, histones, remain constant in the brain, never changing after ... Sinai have discovered that histones are steadily replaced in brain cells throughout life – ...
(Date:7/1/2015)... ... July 01, 2015 , ... A healthy ... raised chickens and eggs. Eating organic foods and products can help limit the ... environmentally friendly than production chicken farming. Choosing home raised chickens and eggs that ...
(Date:7/1/2015)... ... July 01, 2015 , ... OncLive® will ... of America (HCA), as it further expands its Strategic Alliance Partnership Program for ... this new partnership, OncLive’s editorial and marketing teams will collaborate with Sarah Cannon ...
(Date:7/1/2015)... Colorado) , ... - (PRWEB) July 01, 2015 , ... ... a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her ... a highly decorated soldier and recipient of the Bronze Star Medal, died during a ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... contributing to newly released white paper: “Pro-actively Identifying the High-Cost Patient Population: Insights ... 1st and is available at: http://www.hcttf.org/resouces-tools . , The Healthcare Transformation Task ...
Breaking Medicine News(10 mins):Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:Chicken Coop Condo Offer New Chicken Coop Designs 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 2Health News:A Population Based Approach to Pay for Value: RowdMap, Inc. Contributes to Health Care Transformation Task Force White Paper 3
... seaweed and glow-in-the-dark biochemical agents may hold the ... cells to treat patients with severe peripheral arterial ... basic scientists and interventional radiologists at Johns Hopkins. ... in rabbits, Johns Hopkins scientists safely and successfully ...
... (ABI) Identifies Peripheral Arterial Disease Patients at High ... Score in 6,200-Person NHANES StudySAN DIEGO, Calif., March ... available screening tests--like the ankle brachial index (ABI)--along ... Risk Score--has the potential to prevent devastating heart ...
... Certification Underscores Lionbridge,s Market-Leading Translation Management Program ... 10 Lionbridge (Nasdaq: LIOX ... ISO 13485:2003 certification which verifies quality management ... expands Lionbridge,s dedicated Life Sciences program and ...
... NOVATO, Calif., March 10 BioMarin Pharmaceutical Inc. (Nasdaq: ... Vice President and Chief Financial Officer of BioMarin, will present ... Health Care Conference in Boston on Tuesday, March 17th, 2009 ... live audio webcast of the conference call via the investor ...
... , , TUESDAY, March 10 (HealthDay News) -- A comprehensive ... workload faced by physicians, according to researchers who examined ... Permanente health plan. , Among its features, the system ... instead of a traditional office visit. The system was ...
... Leukemia & Lymphoma Society(R)PRINCETON, N.J., March 10 ... has been treated in its Phase 2 multicenter, ... Injection versus intensive salvage therapy in adult patients ... leukemia in first relapse. As previously announced, ...
Cached Medicine News:Health News:Seaweed and fireflies brew may guide stem cell treatment for peripheral artery disease 2Health News:Simple Test Helps Predict Heart Attack Risk 2Health News:Simple Test Helps Predict Heart Attack Risk 3Health News:Simple Test Helps Predict Heart Attack Risk 4Health News:Lionbridge Receives ISO 13485:2003 Certification for Quality Management 2Health News:BioMarin to Present at the Cowen and Company 29th Annual Health Care Conference 2Health News:Electronic Communication May Be Boon to Doctors' Time 2Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 2Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 3Health News:Celator(R) Pharmaceuticals Enrolls First Patient in Its Phase 2 Study of CPX-351 in Acute Myeloid Leukemia in First Relapse 4
(Date:7/1/2015)... , July 1, 2015 Qiming Venture ... to Managing Partner effective immediately. William ... has lead and participated in many Qiming healthcare deals, ... in the Chinese market. Qiming, s success in healthcare ... he has distinguished himself with his outstanding advocacy and ...
(Date:7/1/2015)... 1, 2015 ExeGi Pharma, a company focused ... announced today that it has been granted a product ... Products Directorate (NNHPD) to sell Visbiome™ in ... by Professor Claudio De Simone , MD, PhD ... Professor De Simone recently signed an exclusive agreement with ...
(Date:7/1/2015)... -- According to a new market research ... (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral), by ... to 2020", published by MarketsandMarkets, the Transfection Reagents and ... by 2020 with a CAGR of 7.2% from 2014 ... ables and 33 F igures ...
Breaking Medicine Technology:Qiming Announces the Promotion of William Hu to Managing Partner 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 2ExeGi Pharma Secures Canadian Approval For Well Studied Probiotic 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4
Our soft guedel airway is clear and has a color coded bite block. Airway has a smooth finish and is Latex Free. Recommended for single use. Non-Sterile....
Rsch color coded Guedel airways offer our best value on oropharyngeal airways. They uniquely combine color coding for size and flexible material without a premium price. Color coded airways are latex...
New - Color Coded Berman Airways. A simple idea makes size identification easier for you., ,Premium upgrade without a premium price. Color Coded Berman airways are latex-free., ,Plastic. Single use...
Plastic. Economical. Single use. Non-Sterile....
Medicine Products: